0183 Progranulin (PC-derived growth factor) levels in serum do not predict response to neoadjuvant capecitabine (X), docetaxel (T) and trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC)
H. Wildiers, I. Buysschaert, A. Van Hootegem, A. Smeets, I. Vanden Bempt, P. Neven, P. Moerman, P. Schöffski, R. Paridaens, D. LambrechtsVolume:
18
Year:
2009
Language:
english
Pages:
1
DOI:
10.1016/s0960-9776(09)70206-1
File:
PDF, 63 KB
english, 2009